Antisoma to present at J.P. Morgan Healthcare Conference
07 January 2010, London, UK, and Cambridge, MA: Antisoma plc (LSE: ASM; USOTC:
ATSMY) announces that its Chief Executive Officer, Glyn Edwards, will present an
overview of the Company's strategy, programmes and prospects at the 28th Annual
J.P. Morgan Healthcare Conference in San Francisco, on Thursday, January 14th at
11:30 PST/19:30 GMT.
A webcast of the presentation will be available on Antisoma's website at
http://www.antisoma.com/asm/media/webcast/
For live viewing of the webcast, it is recommended that viewers log on 15
minutes early in order to register and download any necessary software.
Enquiries
Daniel Elger
VP, Marketing and Communications
Antisoma plc
+44 (0) 20 3249 2100
Background on Antisoma
Antisoma is a London Stock Exchange-listed biopharmaceutical company that
develops novel products for the treatment of cancer. The Company has operations
in the UK and the US. Please visit www.antisoma.com for further information
about Antisoma.
[HUG#1371069]
